DNMT inhibitor (Zebularine) degrades HIF-1α and overcomes hypoxia-induced Oxaliplatin resistance by upregulating the activity of pyruvate dehydrogenase (PHD) that activated PHD increases the conversion from pyruvate to acetyl CoA for oxidation in CRC mice model [105]. The gene discussed is PDC; the disease is colorectal carcinoma.